Blog & News
State Health Compare Adds New Social Determinants Measure: Percent of Children with Adverse Childhood Experiences
September 14, 2020:A new State Health Compare measure examines the prevalence and degree of adverse childhood experiences (ACEs) among different demographic groups, with estimates available across the states and over time.
What are ACEs?
The Centers for Disease Control and Prevention (CDC) defines ACEs as “potentially traumatic events that occur in childhood (0-17 years)” including experiencing violence, abuse, or neglect; witnessing violence in the home or community; or having a family member attempt or die by suicide. ACEs also include “aspects of the child’s environment that can undermine their sense
of safety, stability, and bonding,” such growing up in a household with substance misuse, mental health problems, and instability due to parental separation or household members being in jail or prison.i
Why are ACEs Important?
A landmark study conducted in the 1990s found a significant relationship between the number of ACEs an individual experienced and a variety of negative outcomes in adulthood, including poor physical and mental health, substance abuse, and risky behaviors (e.g., smoking, having a history of sexually transmitted disease/infection, etc.). The more ACEs an individual experienced, the greater the risk of these outcomes.ii Because ACEs are common, with about 61% of adults reporting at least one type of ACE and nearly one in six reporting four or more types of ACEs, preventing ACEs
could reduce a large number of negative physical and behavioral health outcomes.iii
How Can We Prevent ACEs?
Creating and sustaining safe, stable, nurturing relationships and environments for children and families can prevent ACEs.iv Data on the prevalence and severity of ACEs among different groups can help policymakers and public health professionals target prevention efforts effectively so that resources are efficiently leveraged to support these relationships and environments where they are most needed.
What Can We Learn from the State Health Compare Estimates?
The ACEs estimates presented in State Health Compare indicate the percent of children with no ACEs, the percent of children with one ACE, and the percent of children with multiple ACEs. Breakdowns are available by age, insurance coverage type, education, poverty level, and race/ethnicity. Available time periods are the two-year pooled periods of 2016-2017 and 2017-2018
Children with ACEs: Data Highlights
Nationwide, an estimated 18.6% of all children (age 0-17) had multiple ACEs in 2017-2018, 23.3% had one ACE, and 58.2% had zero ACEs. The following section takes a quick dive into the percentages of children with multiple ACEs to highlight some of the subgroup analyses that are available using State Health Compare.
Percent of Children with Multiple ACEs: By Age Group
Figure 1 shows the national rates of children with multiple ACEs and state high and low rates for different age groups of children, with rates tending to be higher among older children and lower among younger children. Overall, the lowest percentage of children with multiple ACEs by age was 5.1% among 0-5 year-olds in Wisconsin, and the highest percentage was 42.1% among 12-17 year-olds in the District of Columbia (DC).
Percent of Children with Multiple ACEs: By Race/Ethnicity
Figure 2 shows the national rates and state high and low rates for children with multiple ACEs by race/ethnicity in 2017-2018. When examining the national rate of children with multiple ACEs by race/ethnicity, as well as state-level highs and lows for this measure, White children consistently ranked at the bottom, with the lowest percentage being 4.4% among White children living in DC. The highest nation- wide percentage of children with multiple ACEs by race/ethnicity was among African American/Black children, of whom 28% had more than one ACE. The highest state-level percentage was 41.8% among Hispanic/Latino children living in Alaska.
Percent of Children with Multiple ACEs: By Insurance Coverage Type
Figure 3 shows the percentage of children with two or more ACEs according to insurance status in 2017-2018. Nationwide, the highest proportion of children reporting multiple ACEs was among those with public coverage, at 31.6 percent. This is more than 2.5 times the nationwide low of 12.1 percent among children with private coverage. At the state level, a low of 7.9 percent of privately insured children in Massachusetts reported multiple ACEs, versus a high of 50.5 percent of publicly insured children in Wyoming.
Percent of Children with Multiple ACEs: By Poverty Level
Figure 4 shows the prevalence of multiple ACEs by poverty level in 2017-2018. The national percentage of children who had multiple ACEs by poverty level was highest among children at 0 to 199 FPG at 27.4 percent. This proportion was lowest among children in household with incomes at or above 400 percent of the Federal Poverty Guideline (FPG) at 8.1 percent—a 19.3 percentage-point difference from the rate for high-income children. At the state level, the highest percentages of children with multiple ACES by poverty level were 39.7 percent among children at 200 to 299 percent FPG living in DC and 39.0 percent among children at 0 to 199 percent FPG living in Montana. The state low for multiple
ACEs by poverty level was 5.0 percent among children at
or above 400 percent FPG living in Delaware.
Learn More
To explore State Health Compare’s ACEs estimates further, visit State Health Compare at statehealthcompare.shadac.org and click on “Explore Data.”
Other social and economic factors that can be explored through State Health Compare include:
i Centers for Disease Control and Prevention (CDC). (April 2020). “Preventing Adverse Childhood Experiences.” Available at https://www.cdc.gov/violenceprevention/acestudy/fastfact.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fviolenceprevention%2Fchildabuseandneglect%2Faces%2Ffastfact.html
ii Felitti, V.J., Anda, R.F., Nordenberg, D., Edwards, B.A., Koss, M.P., Marks, J.S. (May 1998). “Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults.” American Journal of Preventive Medicine 14(4): 245-258. DOI: 10.1016/S0749-3797(98)00017-8.
iii Centers for Disease Control and Prevention (CDC). (April 2020). “Preventing Adverse Childhood Experiences.” Available at https://www.cdc.gov/violenceprevention/acestudy/fastfact.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fviolenceprevention%2Fchildabuseandneglect%2Faces%2Ffastfact.html
iv Ibid.
Blog & News
After drop in 2018, newer data indicate a resurgence in drug overdose deaths
August 26, 2020:While new SHADAC research found small but statistically significant declines in opioid and drug overdose death rates during 2018, newer data indicate those reductions may have been short-lived. Overall, in 2018, drug overdose death rates declined 4.6 percent as compared to the prior year, but our analysis also found variation in amounts and direction of changes in individual types of drugs. For instance, overdose death rates from prescription opioids dropped 14.7 percent and those from heroin dropped 3.8 percent, but overdose death rates from synthetic opioids (e.g., fentanyl) increased 9.6 percent and those from psychostimulants (e.g., methamphetamine) grew 22.1 percent.
Provisional data published by the U.S. Centers for Disease Control and Prevention show evidence of an increase in overall drug overdose deaths in 2019, as well as for certain individual types of drugs. During a rolling 12-month period ending in December 2019, drug overdose deaths reached a record high of 70,980—a 4.6 percent increase over the 12-month period ending in December 2018.1 And among the states, 36 of 50 saw increases in their reported drug overdose deaths. In that same amount of time, overdose deaths from synthetic opioids increased 15.8 percent and overdose deaths from psychostimulants increased 26.8 percent.
The state of Minnesota also recently published its own preliminary data on drug overdose deaths in 2019, finding similar patterns to the U.S. After experiencing a decline in drug overdose deaths in 2018, Minnesota reported that preliminary data showed a 20 percent increase in overall drug overdoses in 2019—in addition to synthetic opioid overdose deaths that increased by 48 percent, and psychostimulant overdose deaths that grew by 37 percent.2
Some reports also indicate that drug overdose deaths may have spiked in early 2020, coinciding with the beginning of the coronavirus pandemic and various associated stressors. For example, a White House analysis found an 11.4 percent increase in overdose deaths in the first four months of 2020 as compared to the prior year.3 In the midst of the COVID-19 emergency, experts such as those from the National Academy of Medicine have raised concerns that “the nation is experiencing an unprecedented convergence of epidemics, and there is great concern that the opioid crisis…may only worsen in the absence of a concerted response.”4
As new data on drug overdoses become available in the coming months and years, it will be vital to monitor the continually shifting dynamics of the opioid crisis, to identify early the emerging patterns—such as the rise of synthetic opioids and psychostimulants—and to continue to guide policy efforts to address the persistent public health emergencies of substance use and drug overdose deaths.
Explore SHADAC's most recent analysis of the Widening Drug Overdose Crisis in the United States or visit our Opioid Epidemic Resources page to access all opioid-related analysis done by SHADAC researchers over the last several years.
1 Ahmad, F.B., Rossen L.M., & Sutton, P. (2020). Provisional drug overdose death counts [National Center for Health Statistics report]. Available from https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
2 DeLaquil, M., Giesel, S., & Wright, N. (n.d.). Preliminary 2019 drug overdose deaths: A return to the states’ overall trend [PDF file]. Retrieved from https://www.health.state.mn.us/communities/opioids/documents/2019prelimdeathreport.pdf
3 Ehley, B. (2020, July 2). Pandemic unleashes a spike in overdose deaths. Politico. Retrieved from https://www.politico.com/news/2020/06/29/pandemic-unleashes-a-spike-in-overdose-deaths-345183
4 National Academy of Medicine. (2020). Mapping our impacts. Available from https://nam.edu/programs/action-collaborative-on-countering-the-u-s-opioid-epidemic/mapping-our-impact/
Publication
Overdose Crisis in Transition: Changing National and State Trends in a Widening Drug Death Epidemic
For nearly two decades, the United States has experienced a growing and evolving crisis of substance abuse and addiction; a crisis illustrated by statistically significant increases in overdose deaths directly from, or related to, opioids. These increases have occurred throughout the country, as the annual number of drug overdose deaths has nearly quadrupled from 17,500 in 2000 to 67,400 in 2018, and nearly every state has experienced increases in overdose deaths from one or more types of opioids since 2000.1,2
In the years since the U.S. Centers for Disease Control and Prevention (CDC) declared overdoses from prescription painkillers an “epidemic” in 2011, the opioid overdose crisis has evolved rapidly from a problem tied mostly to prescription opioid painkillers to one driven by illicitly trafficked heroin, to one marked by the rise of synthetic opioids, to most recently one with surging numbers of overdose deaths related to cocaine and psychostimulants—non-opioid illicit substances that have been linked to the opioid crisis via emerging evidence from both the CDC and U.S. Drug Enforcement Administration (DEA).3,4
Variations in the opioid and opioid-related drug overdose crisis have become especially pronounced in recent years. While data from the CDC has shown that drug overdose deaths overall and opioid overdose deaths in aggregate declined a small but statistically significant amount from 2017 to 2018 (4.6 percent), examining data at a more granular level shows a more nuanced picture. While deaths from prescription opioids and heroin declined in 2018, deaths from synthetic opioids, cocaine, and psychostimulants increased significantly to reach new record highs.
As a result of these more current variations, SHADAC’s annually produced opioid and opioid-related drug overdose briefs have shifted slightly in order to particularly focus on changes in overdose deaths across the nation and among the states in more recent years, especially in 2018. The briefs provide high-level information about opioids and opioid addiction, present the historical context for the epidemic of opioid and related addiction and mortality in the United States, and examine trends in opioid-related mortality across the country and among population subgroups between 2017 and 2018.
Related Resources
The Opioid Epidemic in the United States
50-State Analysis of Drug Overdose Trends: The Evolving Opioid Crisis Across the States (Infographics)
After drop in 2018, newer data indicate a resurgence in drug overdose deaths (Blog)
The Evolving Opioid Epidemic: Observing the Changes in the Opioid Crisis through State-level Data (Webinar)
The Opioid Epidemic: National and State Trends in Opioid-Related Overdose Deaths from 2000 to 2017 (Briefs)
1 Hedegaard, H., Miniño, A.M., & Warner, M. (2020). Drug overdose deaths in the United States, 1999-2018 [Data brief No. 356]. Retrieved from https://www.cdc.gov/nchs/data/databriefs/db356-h.pdf
2 State Health Access Data Assistance Center (SHADAC). (2019). The opioid epidemic: State trends in opioid-related overdose deaths from 2000 to 2017 [PDF file]. Available from http://www.shadac.org/2017OpioidBriefs
3 Kariisa, M., Scholl, L., Wilson, N., Seth, P., & Hoots, B. (2019, May 3). Drug overdose deaths involving cocaine and psychostimulants with abuse potential—United States, 2003-2017. MMWR, 68(17), 388-395. DOI: http://dx.doi.org/10.15585/mmwr.mm6817a3
4 Drug Enforcement Administration (DEA) Strategic Intelligence Section. (2020). 2019 National Drug Threat Assessment [DEA-DCT-DIR-007-20]. Retrieved from https://www.dea.gov/sites/default/files/2020-01/2019-NDTA-final-01-14-2020_Low_Web-DIR-007-20_2019.pdf